DCR

mGC or mGEJC - L2 - all population metastatic/advanced mGC or mGEJC mGC or mGEJC - 2nd Line (L2) mGC or mGEJC - L2 - all population

versus irinotecan
avelumab alone vs. irinotecan 1 -1926 [-2818; -1033] /10000
34/185 vs. 70/186